About Nabla Bio
Our mission is to enable pharmaceutical and biotech companies to bring more antibody therapies to patients. Using AI and massively parallel experimentation, we design antibodies that precisely bind the disease target at the right location, while minimizing manufacturability and toxicity risks. We are a well-funded, revenue-generating, bilingual company of wet- and dry-lab scientists, and are founded by AI and protein design experts from Harvard University.
Founded in 2021 by Frances Anastassacos and Surge Biswas.
- Founded
- 2021
- Employees
- 8
- Total funding
- $37.4M
- Headquarters
- Cambridge
Leadership
The top of Nabla Bio's org chart, with how many people report into each leader.
Surge Biswas
Co-Founder & CEO
9 reports
Vinicius Reis
Senior ML Scientist
5 reports
Connor Blankenship
Senior Scientist
1 report
Sunita Subramanian
Senior Scientist
Open roles at Nabla Bio
Still listed on Nabla Bio's careers site, first posted over a year ago.
- AI Platform Engineer
Cambridge, United States · Posted Aug 2025
- AI Scientist
Cambridge, United States · Posted Aug 2025
- Applied AI/Bio Scientist
Cambridge, United States · Posted Aug 2025